A recent study reported that high SKA3 expression is associated with poor clinical outcomes and muscle-invasive bladder cancer progression, and promotes bladder cancer cell proliferation by accelerating G2/M transition [28]. The gene discussed is SKA3; the disease is urinary bladder carcinoma.